Ladder Health, a provider of AI-powered virtual-first pediatric developmental care, secured a $7 million Seed round led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, and incubating partner 25madison Health.
The Ladder Health fund raise reflects growing conviction among healthcare investors that caregiver-activated, technology-enabled models represent the most scalable response to the pediatric workforce shortage, as demand for developmental services continues to surge and the gap between need and access widens.
Mitch Mudra, co-founder and CEO of Ladder Health, said: “Early developmental therapy changes life trajectories, but only if families can actually access it at the right time.”
“Half of families in the U.S. rely on Medicaid, and the system simply wasn’t built to serve them well. We built Ladder Health for this moment, when the demand for care exceeds the system’s capacity and too many families are left without access to the care their children need,” added Mitch Mudra.
Other notable investors in Seed funding round include Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital, and 7Rock Ventures. The funding will support expansion across North Carolina, Massachusetts, and Maryland, accelerate entry into additional states, and continue investment in Ladder Health’s AI-enabled care platform and health system partnerships.
Digital health companies, including AI-powered specialized pediatric care startups, have secured more than $180 billion in funding to date, according to our recent Funding Database. More recently, Los Angeles-based startup Village (village.health) has raised $9.5 million in an equity funding round to scale its AI-enabled, pediatric care network across the U.S. The investment round was led by Upfront Ventures, with participation from Bling Capital, GTMFund, and Perceptive Ventures.
In another deal, 9amHealth, an AI-enabled virtual specialty care startup, raised $26 million in a Series B funding round led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures.